Advanced Cell Diagnostics

Acquired

Newark, United States · Founded 2006 · $270K raised

Headquarters
Newark, California
Employees
51–200
Founded
2006
Business Model
B2B
Website
acdbio.com
Total Funding
$270K
Last Round
$270K GrantJan 2015
Rounds
2
Acquired by
Bio-TechneAug 2016 · $250.0M

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Advanced Cell Diagnostics (ACD) develops and commercializes proprietary consumables for genomic analysis, best known for its RNAscope RNA in-situ hybridization technology, which visualizes gene expression in individual cells while preserving tissue morphology. Founded in 2006 by Dr. Yuling Luo and Dr. Steve Chen, ACD grew to over 100 employees and a catalog of more than 9,000 probe reagents used in thousands of academic and industrial labs. Headquartered in Newark, California with field offices in Italy, China, and Japan, ACD was acquired by Bio-Techne Corporation in 2016 for $250 million plus up to $75 million in contingent consideration.

Summary

Advanced Cell Diagnostics is a Biotech company based in Newark, United States, founded in 2006. It has raised $270K in total across 2 rounds, most recently a $270K Grant round in Jan 2015. Investors include Bio-Techne Corporation and Summit Partners.

Funding & Exit History

AcquisitionAug 2016

Sign up to see all 3 events

Funding: Series C through Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Advanced Cell Diagnostics on Indexed.vc
<a href="https://indexed.vc/companies/advanced-cell-diagnostics"><img src="https://indexed.vc/api/badge/company/advanced-cell-diagnostics" alt="Advanced Cell Diagnostics on Indexed.vc" width="260" height="76" /></a>